BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 12777372)

  • 1. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets.
    Arsham AM; Howell JJ; Simon MC
    J Biol Chem; 2003 Aug; 278(32):29655-60. PubMed ID: 12777372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-induced energy stress regulates mRNA translation and cell growth.
    Liu L; Cash TP; Jones RG; Keith B; Thompson CB; Simon MC
    Mol Cell; 2006 Feb; 21(4):521-31. PubMed ID: 16483933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation.
    Alam H; Maizels ET; Park Y; Ghaey S; Feiger ZJ; Chandel NS; Hunzicker-Dunn M
    J Biol Chem; 2004 May; 279(19):19431-40. PubMed ID: 14982927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4′,6-dihydroxy-4-methoxyisoaurone inhibits the HIF-1α pathway through inhibition of Akt/mTOR/p70S6K/4E-BP1 phosphorylation.
    Mi C; Ma J; Shi H; Li J; Wang F; Lee JJ; Jin X
    J Pharmacol Sci; 2014; 125(2):193-201. PubMed ID: 25075425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.
    Li G; Shan C; Liu L; Zhou T; Zhou J; Hu X; Chen Y; Cui H; Gao N
    PLoS One; 2015; 10(2):e0117440. PubMed ID: 25659153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons.
    Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC
    J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells.
    Bishop JD; Nien WL; Dauphinee SM; Too CK
    J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tuberous sclerosis protein TSC2 is not required for the regulation of the mammalian target of rapamycin by amino acids and certain cellular stresses.
    Smith EM; Finn SG; Tee AR; Browne GJ; Proud CG
    J Biol Chem; 2005 May; 280(19):18717-27. PubMed ID: 15772076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I.
    Treins C; Giorgetti-Peraldi S; Murdaca J; Monthouël-Kartmann MN; Van Obberghen E
    Mol Endocrinol; 2005 May; 19(5):1304-17. PubMed ID: 15695372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif.
    Nojima H; Tokunaga C; Eguchi S; Oshiro N; Hidayat S; Yoshino K; Hara K; Tanaka N; Avruch J; Yonezawa K
    J Biol Chem; 2003 May; 278(18):15461-4. PubMed ID: 12604610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P; Mateo J
    Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of simian virus 40 large and small tumor antigens on mammalian target of rapamycin signaling: small tumor antigen mediates hypophosphorylation of eIF4E-binding protein 1 late in infection.
    Yu Y; Kudchodkar SB; Alwine JC
    J Virol; 2005 Jun; 79(11):6882-9. PubMed ID: 15890927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of rapamycin sensitivity in breast cancer cells.
    Noh WC; Mondesire WH; Peng J; Jian W; Zhang H; Dong J; Mills GB; Hung MC; Meric-Bernstam F
    Clin Cancer Res; 2004 Feb; 10(3):1013-23. PubMed ID: 14871980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity.
    Huang S; Shu L; Easton J; Harwood FC; Germain GS; Ichijo H; Houghton PJ
    J Biol Chem; 2004 Aug; 279(35):36490-6. PubMed ID: 15218033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase.
    Kimball SR; Siegfried BA; Jefferson LS
    J Biol Chem; 2004 Dec; 279(52):54103-9. PubMed ID: 15494402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rapid activation of protein synthesis by growth hormone requires signaling through mTOR.
    Hayashi AA; Proud CG
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1647-55. PubMed ID: 17284572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
    Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes.
    Pham PT; Heydrick SJ; Fox HL; Kimball SR; Jefferson LS; Lynch CJ
    J Cell Biochem; 2000 Sep; 79(3):427-41. PubMed ID: 10972980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
    Dreyer HC; Glynn EL; Lujan HL; Fry CS; DiCarlo SE; Rasmussen BB
    J Appl Physiol (1985); 2008 Jan; 104(1):27-33. PubMed ID: 17885021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors.
    Ducker GS; Atreya CE; Simko JP; Hom YK; Matli MR; Benes CH; Hann B; Nakakura EK; Bergsland EK; Donner DB; Settleman J; Shokat KM; Warren RS
    Oncogene; 2014 Mar; 33(12):1590-600. PubMed ID: 23542178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.